Cedars-Sinai Cancer | Strategic Alliance Partners

Cedars-Sinai Cancer in Los Angeles serves one of the most diverse regions globally. Ranked No. 7 for cancer by U.S. News & World Report 2020-2021, the center’s clinicians are committed to providing compassionate, state-of-the-art care, while its scientists are carrying out the latest translational research and groundbreaking advances. The cancer enterprise includes the Samuel Oschin Comprehensive Cancer Institute, The Angeles Clinic and Research Institute, Tower Hematology Oncology Medical Group, Torrance Memorial Hunt Cancer Center and Cedars-Sinai Tarzana.

Latest from Cedars-Sinai Cancer

Dr. Atkins on Safety Considerations For Neoadjuvant Approaches in Gastric Cancer

June 14, 2021

Video

Katelyn M. Atkins, MD, PhD, discusses safety considerations for neoadjuvant approaches in patients with gastric cancer.

Role of Adjuvant Chemoradiation Under Study in Gastric Cancer

May 16, 2021

Article

Katelyn M. Atkins, MD, PhD, examines the evolving role of radiotherapy in the treatment of patients with gastric cancer, the subgroups who might derive the most benefit from this approach, and ongoing research efforts that are seeking to address remaining questions with this modality.

Gong Gives Perspective on Sequencing Challenges Faced in Advanced HCC

May 14, 2021

Article

Jun Gong, MD, discusses the impact of the IMbrave150 trial on the advanced HCC treatment paradigm and challenges faced with sequencing.

The Future of Cancer Immunotherapy Lies in Combinational Approaches

May 06, 2021

Article

Arsen Osipov, MD, discusses the potential for ongoing research with immunotherapeutic approaches in gastrointestinal malignancies, including CAR T-cell therapy, bispecific T-cell engagers, and vaccines.

Dr. Osipov on the Role of Combination Immunotherapy Across Multiple Tumor Types

April 30, 2021

Video

Arsen Osipov, MD, discusses the role of combination immunotherapy across multiple tumor types.

Dr. Atkins on the Role of Adjuvant Chemoradiation in Gastric Cancer

April 14, 2021

Video

Katelyn M. Atkins, MD, PhD, discusses the role of adjuvant chemoradiation therapy in gastric cancer.

Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 1

January 13, 2021

Article

Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC

June 05, 2020

Video

Jean Lopategui, MD, discusses the evolution of targeted therapies in non–small cell lung cancer.

Dr. Natale on the Evolution of Immunotherapy in NSCLC

May 15, 2020

Video

Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.

Dr. Natale on the Evolution of Immunotherapy in NSCLC

May 14, 2020

Video

Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.

Dr. Freedland on Real-World Utility of Enzalutamide in Prostate Cancer

May 12, 2020

Video

Stephen J. Freedland, MD, discusses remaining questions with the real-world utility of enzalutamide in prostate cancer.

Dr. Freedland on Real-World Utility of Enzalutamide in Prostate Cancer

May 11, 2020

Video

Stephen J. Freedland, MD, discusses remaining questions with the real-world utility of enzalutamide in prostate cancer.

Dr. Lopategui on the Evolution of Molecular Testing in NSCLC

May 05, 2020

Video

Jean Lopategui, MD, discusses the evolution of molecular testing in non–small cell lung cancer.

Dr. Reckamp on Navigating Challenges Posed by COVID-19

April 14, 2020

Video

Karen L. Reckamp, MD, MS, provides insight on how she is navigating challenges posed by the COVID-19 crisis.

Dr. Freedland on Real-World Evidence Vs PREVAIL Trial in mCRPC

March 27, 2020

Video

Stephen J. Freedland, MD, discusses how real-world evidence with the use of enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) compares with data from the phase III PREVAIL trial.

Dr. Freedland on the Importance of Conducting Real-World Analyses in Prostate Cancer

March 10, 2020

Video

Stephen J. Freedland, MD, discusses the importance of conducting real-world analyses in prostate cancer.

Dr. Mirhadi on Patient Populations of Lung Cancer Optimal for Radiation

March 04, 2020

Video

Amin J. Mirhadi, MD, discusses patient populations of lung cancer who should be treated with radiation therapy.

Dr. Figlin on Novel Combinations in Kidney Cancer Treatment

March 02, 2020

Video

Robert A. Figlin, MD, discusses novel combinations in the treatment of patients with kidney cancer.

Dr. Reckamp on Targeted Therapy Options for Rare Mutations in NSCLC

February 28, 2020

Video

Karen L. Reckamp, MD, MS, discusses targeted therapy options for rare mutations in non–small cell lung cancer.

Immunotherapy Makes Waves in Small Cell Lung Cancer

February 28, 2020

Article

Alain C. Mita, MD, discusses the impact of immunotherapy in the frontline and recurrent settings for patients with small cell lung cancer.